Ironwood Pharmaceuticals Inc (IRWD) — 10-Q Filings
All 10-Q filings from Ironwood Pharmaceuticals Inc. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Ironwood's Q3 Net Income Soars 1000% on Revenue Growth, Cost Cuts
— Nov 10, 2025 Risk: medium
IRONWOOD PHARMACEUTICALS INC reported a significant increase in net income for the three months ended September 30, 2025, reaching $40.08 million, up from $3.65 -
Ironwood Q2 Net Income Dips Amid Flat Revenue
— Aug 11, 2025 Risk: medium
IRONWOOD PHARMACEUTICALS INC reported total revenues of $110.0 million for the three months ended June 30, 2025, a decrease from $112.0 million in the prior-yea -
Ironwood Pharmaceuticals Files Q1 2025 10-Q
— May 12, 2025 Risk: medium
Ironwood Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial performance and operations. Key f -
Ironwood Pharma Q3 Sales Hit $800K
— Nov 7, 2024 Risk: low
Ironwood Pharmaceuticals Inc. reported its third-quarter 2024 results, with net sales for the three months ended September 30, 2024, reaching $800,000. The comp -
Ironwood Pharma Q2 2024 10-Q Filed
— Aug 8, 2024 Risk: medium
Ironwood Pharmaceuticals Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the secon -
Ironwood Pharmaceuticals Inc. Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: medium
IRONWOOD PHARMACEUTICALS INC (IRWD) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Ironwood Pharmaceuticals Inc. filed a 10-Q report for the perio
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX